Corbus Pharmaceuticals Holdings, Inc. Quarterly Interest Expense in USD from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2013 to Q2 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Interest Expense for the quarter ending June 30, 2024 was $652K, a 35.3% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Interest Expense for 2015 was $2.44K, a 89.8% decline from 2014.
  • Corbus Pharmaceuticals Holdings, Inc. annual Interest Expense for 2014 was $24K, a 46.8% decline from 2013.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $652K -$356K -35.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q2 2023 $1.01M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2016 $7.89K $6.43K +$5.45K +557% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-13
Q4 2015 $2.44K $1.07K +$92.00 +9.43% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-28
Q3 2015 $2.35K $0 -$650 -100% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-10
Q2 2015 $3K $393 -$10.8K -96.5% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $13.8K $979 -$10.2K -91.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $24K $976 Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 $650 -$8.72K -93.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $11.2K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $11.2K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 $9.37K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.